Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)
Prospective, Non-interventional Study of Disease Progression and Treatment of Patients With Polycythemia Vera in United States Academic or Community Clinical Practices
Sponsor: Incyte Corporation
Listed as NCT02252159, this observational or N/A phase trial focuses on MPN (Myeloproliferative Neoplasms) and remains completed. Sponsored by Incyte Corporation, it has been updated 17 times since 2014, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
17 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
May 2021 — Dec 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 12 earlier versions
-
Jan 2021 — May 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Jul 2019 — Nov 2020 [monthly]
Active Not Recruiting
-
Mar 2019 — Jul 2019 [monthly]
Active Not Recruiting
-
Jul 2018 — Mar 2019 [monthly]
Active Not Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — May 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Feb 2018 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Oct 2017 — Feb 2018 [monthly]
Active Not Recruiting NA
-
Aug 2017 — Oct 2017 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
First recorded
Jul 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Incyte Corporation
For direct contact, visit the study record on ClinicalTrials.gov .